Longitudinal study of seroprevalence and serostability of the human polyomaviruses JCV and BKV in organ transplant recipients

Journal of Medical Virology

Volumn 85, Issue 2, 2013, Pages 327-335

  Antonsson, Annika ^a   Pawlita, Michael ^b   Feltkamp, Mariet C W ^c   Bouwes Bavinck, Jan N ^c   Euvrard, Sylvie ^d   Harwood, Catherine A ^e   Naldi, Luigi ^f   Nindl, Ingo ^g   Proby, Charlotte M ^e   Neale, Rachel E ^a   Waterboer, Tim ^b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f OSPEDALI RIUNITI   (Italy)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

BKV; Immunosuppression; JCV; Organ transplantation; Seroprevalence; Serostability

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGE; ANTIBODY RESPONSE; ARTICLE; BK VIRUS; EUROPE; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; JC VIRUS; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; SEROPREVALENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; BK VIRUS; CHILD; CHILD, PRESCHOOL; EUROPE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; JC VIRUS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; SEROEPIDEMIOLOGIC STUDIES; TRANSPLANTATION; TRANSPLANTS; YOUNG ADULT;

BK POLYOMAVIRUS; POLYOMAVIRUS;

EID: 84871103113     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23472     Document Type: Article

References (27)

1. Abend JR, Jiang M, Imperiale MJ. 2009. BK virus and human cancer: Innocent until proven guilty. Semin Cancer Biol 19: 252- 260.
2. Antonsson A, Green AC, Mallitt KA, O'Rourke PK, Pawlita M, Waterboer T, Neale RE. 2010. Prevalence and stability of antibodies to the BK and JC polyomaviruses: A long-term longitudinal study of Australians. J Gen Virol 91: 1849- 1853.
3. Bohl DL, Brennan DC, Ryschkewitsch C, Gaudreault-Keener M, Major EO, Storch GA. 2008. BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol 43: 184- 189.
4. Boldorini R, Brustia M, Veggiani C, Barco D, Andorno S, Monga G. 2005. Periodic assessment of urine and serum by cytology and molecular biology as a diagnostic tool for BK virus nephropathy in renal transplant patients. Acta Cytol 49: 235- 243.
5. Boldorini R, Veggiani C, Amoruso E, Allegrini S, Miglio U, Paganotti A, Ribaldone R, Monga G. 2008. Latent human polyomavirus infection in pregnancy: Investigation of possible transplacental transmission. Pathology 40: 72- 77.
6. Carter JJ, Paulson KG, Wipf GC, Miranda D, Madeleine MM, Johnson LG, Lemos BD, Lee S, Warcola AH, Iyer JG, Nghiem P, Galloway DA. 2009. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 101: 1510- 1522.
7. Dorries K. 1998. Molecular biology and pathogenesis of human polyomavirus infections. Dev Biol Stand 94: 71- 79.
8. Dorries K, Vogel E, Gunther S, Czub S. 1994. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 198: 59- 70.
9. Du Pasquier RA, Kuroda MJ, Zheng Y, Jean-Jacques J, Letvin NL, Koralnik IJ. 2004. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 127: 1970- 1978.
10. Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH. 2009. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 199: 837- 846.
11. Ferrante P, Caldarelli-Stefano R, Omodeo-Zorini E, Vago L, Boldorini R, Costanzi G. 1995. PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy. J Med Virol 47: 219- 225.
12. Gardner SD, Field AM, Coleman DV, Hulme B. 1971. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1: 1253- 1257.
13. Giraud G, Bogdanovic G, Priftakis P, Remberger M, Svahn BM, Barkholt L, Ringden O, Winiarski J, Ljungman P, Dalianis T. 2006. The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Haematologica 91: 401- 404.
14. Kean JM, Rao S, Wang M, Garcea RL. 2009. Seroepidemiology of human polyomaviruses. PLoS Pathog 5: e1000363.
15. Kjaerheim K, Roe OD, Waterboer T, Sehr P, Rizk R, Dai HY, Sandeck H, Larsson E, Andersen A, Boffetta P, Pawlita M. 2007. Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples. Int J Cancer 120: 2459- 2465.
16. Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DW, Miller E. 2003. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 71: 115- 123.
17. Kwak EJ, Vilchez RA, Randhawa P, Shapiro R, Butel JS, Kusne S. 2002. Pathogenesis and management of polyomavirus infection in transplant recipients. Clin Infect Dis 35: 1081- 1087.
18. Mitterhofer AP, Pietropaolo V, Barile M, Tinti F, Fioriti D, Mischitelli M, Limonta A, Mecule A, Ferretti G, Poli L, Chiarini F, Berloco PB, Taliani G. 2010. Meaning of early polyomavirus-BK replication post kidney transplant. Transplant Proc 42: 1142- 1145.
19. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. 1971. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1: 1257- 1260.
20. Randhawa P, Bohl D, Brennan D, Ruppert K, Ramaswami B, Storch G, March J, Shapiro R, Viscidi R. 2008. Longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients. Clin Vaccine Immunol 15: 1564- 1571.
21. Saundh BK, Tibble S, Baker R, Sasnauskas K, Harris M, Hale A. 2010. Different patterns of BK and JC polyomavirus reactivation following renal transplantation. J Clin Pathol 63: 714- 718.
22. Sehr P, Zumbach K, Pawlita M. 2001. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: Validation for HPV serology. J Immunol Methods 253: 153- 162.
23. Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J. 2003. Seroepidemiology of the human polyomaviruses. J Gen Virol 84: 1499- 1504.
24. van der Meijden E, Kazem S, Burgers MM, Janssens R, Bouwes Bavinck JN, de Melker H, Feltkamp MC. 2011. Seroprevalence of trichodysplasia spinulosa-associated polyomavirus. Emerg Infect Dis 17: 1355- 1363.
25. Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, Templin MF, Pawlita M. 2005. Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins. Clin Chem 51: 1845- 1853.
26. Waterboer T, Neale R, Michael KM, Sehr P, de Koning MN, Weissenborn SJ, Sampogna F, Abeni D, Green AC, Bouwes Bavinck JN, Pawlita M. 2009. Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. J Gen Virol 90: 1986- 1998.
27. Ziedina I, Folkmane I, Chapenko S, Murovska M, Sultanova A, Jushinskis J, Rozental R. 2009. Reactivation of BK virus in the early period after kidney transplantation. Transplant Proc 41: 766- 768.